268 related articles for article (PubMed ID: 34046592)
1. A map of the SARS-CoV-2 RNA structurome.
Andrews RJ; O'Leary CA; Tompkins VS; Peterson JM; Haniff HS; Williams C; Disney MD; Moss WN
NAR Genom Bioinform; 2021 Jun; 3(2):lqab043. PubMed ID: 34046592
[TBL] [Abstract][Full Text] [Related]
2. An
Andrews RJ; Peterson JM; Haniff HS; Chen J; Williams C; Grefe M; Disney MD; Moss WN
bioRxiv; 2020 Apr; ():. PubMed ID: 32511381
[TBL] [Abstract][Full Text] [Related]
3. ScanFold: an approach for genome-wide discovery of local RNA structural elements-applications to Zika virus and HIV.
Andrews RJ; Roche J; Moss WN
PeerJ; 2018; 6():e6136. PubMed ID: 30627482
[TBL] [Abstract][Full Text] [Related]
4. ScanFold 2.0: a rapid approach for identifying potential structured RNA targets in genomes and transcriptomes.
Andrews RJ; Rouse WB; O'Leary CA; Booher NJ; Moss WN
PeerJ; 2022; 10():e14361. PubMed ID: 36389431
[TBL] [Abstract][Full Text] [Related]
5. The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
Tavares RCA; Mahadeshwar G; Wan H; Huston NC; Pyle AM
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268519
[TBL] [Abstract][Full Text] [Related]
6. Mapping the RNA structural landscape of viral genomes.
Andrews RJ; Baber L; Moss WN
Methods; 2020 Nov; 183():57-67. PubMed ID: 31711930
[TBL] [Abstract][Full Text] [Related]
7. RNAStructuromeDB: A genome-wide database for RNA structural inference.
Andrews RJ; Baber L; Moss WN
Sci Rep; 2017 Dec; 7(1):17269. PubMed ID: 29222504
[TBL] [Abstract][Full Text] [Related]
8. A survey of RNA secondary structural propensity encoded within human herpesvirus genomes: global comparisons and local motifs.
Andrews RJ; O'Leary CA; Moss WN
PeerJ; 2020; 8():e9882. PubMed ID: 32974099
[TBL] [Abstract][Full Text] [Related]
9. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.
Rangan R; Zheludev IN; Hagey RJ; Pham EA; Wayment-Steele HK; Glenn JS; Das R
RNA; 2020 Aug; 26(8):937-959. PubMed ID: 32398273
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.
Huston NC; Wan H; Strine MS; de Cesaris Araujo Tavares R; Wilen CB; Pyle AM
Mol Cell; 2021 Feb; 81(3):584-598.e5. PubMed ID: 33444546
[TBL] [Abstract][Full Text] [Related]
11. De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures.
Rangan R; Watkins AM; Chacon J; Kretsch R; Kladwang W; Zheludev IN; Townley J; Rynge M; Thain G; Das R
Nucleic Acids Res; 2021 Apr; 49(6):3092-3108. PubMed ID: 33693814
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in RNA structurome.
Xu B; Zhu Y; Cao C; Chen H; Jin Q; Li G; Ma J; Yang SL; Zhao J; Zhu J; Ding Y; Fang X; Jin Y; Kwok CK; Ren A; Wan Y; Wang Z; Xue Y; Zhang H; Zhang QC; Zhou Y
Sci China Life Sci; 2022 Jul; 65(7):1285-1324. PubMed ID: 35717434
[TBL] [Abstract][Full Text] [Related]
13. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses.
Rangan R; Zheludev IN; Das R
bioRxiv; 2020 Apr; ():. PubMed ID: 32511306
[TBL] [Abstract][Full Text] [Related]
14. Expansion of the RNAStructuromeDB to include secondary structural data spanning the human protein-coding transcriptome.
Rouse WB; O'Leary CA; Booher NJ; Moss WN
Sci Rep; 2022 Aug; 12(1):14515. PubMed ID: 36008510
[TBL] [Abstract][Full Text] [Related]
15. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.
Huston NC; Wan H; de Cesaris Araujo Tavares R; Wilen C; Pyle AM
bioRxiv; 2020 Jul; ():. PubMed ID: 32676598
[TBL] [Abstract][Full Text] [Related]
17. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
18. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
Simmonds P
mBio; 2020 Oct; 11(6):. PubMed ID: 33127861
[TBL] [Abstract][Full Text] [Related]
19. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
Chan AP; Choi Y; Schork NJ
mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
[TBL] [Abstract][Full Text] [Related]
20. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
Elife; 2021 Aug; 10():. PubMed ID: 34402426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
